Anavex Life Sciences Corp (AVXL)

[Gator328]

I grew up with an undersized kid who was always a very good athlete, the best in the neighborhood. Typical big fish in a small pond story. When he signed with a D1 program on an athletic scholarship, a few of us discounted his odds for success because of his size. It wasn't until he turned pro that we had to admit we were wrong.

For a small company like Anavex, peer review provides the same validation that being drafted by a pro team was for my childhood acquaintance. Until then, there will always be skeptics for a number of reasons. Pursuing peer review is a good strategy even if it's frustrating to lose some control over timeliness. Ultimately, it will silence the skeptics and provide additional supporting evidence the FDA cannot ignore.